Nearly two years after Google DeepMind released an updated AlphaFold3 geared at drug discovery, its biopharmaceuticals spin-off, Isomorphic Labs, announced an even more powerful ...

Nearly two years after Google DeepMind released AlphaFold 3, an updated version of its system for predicting protein structure that is geared towards drug discovery, its biopharmaceuticals spin-off, ...

Scientists from Rensselaer Polytechnic Institute (RPI) have used mathematical concepts from string theory, a theoretical description of the mechanics of the entire universe, to upend over a century of ...

Abstract: With the growing exchange of digital images in the Internet of Things (IoT), securing sensitive data, particularly medical images, has become critical. These images are essential for ...

Hannah Harper had Carrie Underwood in tears as she sang about the chaos of being a mom of three young boys during her “American Idol” audition. “I thought finding peace in the quiet’s what I wanted / ...

According to The Rundown AI on X, Isomorphic Labs’ drug-design system more than doubled AlphaFold 3 performance on the hardest protein-ligand cases, signaling major gains in structure-based drug ...

After weeks of waiting and a weather delay, the Mummers String Band competition finally took the field Saturday at Lincoln Financial Field, giving performers and families a long-anticipated moment to ...

Nearly a month after dangerous winds snarled their New Year’s Day performances, a dozen Mummers string bands got their encore. The slate of bands reimagined their Jan. 1 routines Saturday on the ...

Biological systems are notoriously tough to model, especially when it comes to figuring out the axons, neurons, blood vessels, and other structural components of gray matter, or the tissue that makes ...

Abstract: Graph representation learning is a fundamental research theme and can be generalized to benefit multiple downstream tasks from the node and link levels to the higher graph level. In practice ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.